In a report released on January 7, Gregory Renza from RBC Capital maintained a Buy rating on Cormedix (CRMD – Research Report), with a price ...
RBC Capital analyst Brad Heffern lowered the firm’s price target on Centerspace (CSR) to $72 from $76 and keeps an Outperform ...
RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading ...
In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
Find insight on BBVA, Australia’s banks and more in the latest Market Talks covering Financial Services.
RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270.
The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...
Exxon Mobil’s shares fell after the company warned its fourth-quarter earnings will take a hit from lower crude prices and narrowing refining margins during the final three months of 2024.
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Nasdaq (NDAQ – Research Report) yesterday and set a price target of $95.00. The ...
Scotiabank analyst Mario Saric thinks the worst may be over for domestic office REITs, ...